ArticleJournal of the National Comprehensive Cancer Network : JNCCN2012

Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer.

Ravi A Madan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.